A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
VZV Vaccine for Hematopoietic Stem Cell Transplantation
Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients
|5||Not yet recruiting||
Response and Clearance of Viral DNA Following Administration of Live Attenuated Varicella Vaccine in Children With Liver Disease
Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy
Comparison of Serological Test s for the Virus Chicken Pox Virus (VZV) and Correlation With the Patient's Memory of the Infection or Vaccination
Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma/VEGAS
† Study has passed its completion date and status has not been verified in more than two years.